|
FANCL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.76100048274475E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95139460146265E-11 |
| Normal-vs-Stage2 |
1.709200E-01 |
| Normal-vs-Stage3 |
3.95469999999731E-05 |
| Normal-vs-Stage4 |
7.388500E-04 |
| Stage1-vs-Stage2 |
6.117500E-03 |
| Stage1-vs-Stage3 |
1.059820E-01 |
| Stage1-vs-Stage4 |
2.817200E-01 |
| Stage2-vs-Stage3 |
1.417450E-01 |
| Stage2-vs-Stage4 |
1.756790E-01 |
| Stage3-vs-Stage4 |
8.921000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.23969995275064E-09 |
| Normal-vs-AfricanAmerican |
8.559300E-03 |
| Normal-vs-Asian |
1.89569999697881E-08 |
| Caucasian-vs-AfricanAmerican |
8.923600E-01 |
| Caucasian-vs-Asian |
4.755700E-03 |
| AfricanAmerican-vs-Asian |
5.962300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.15499999973213E-07 |
| Normal-vs-Female |
1.3151000288758E-09 |
| Male-vs-Female |
9.497800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.40450009797644E-10 |
| Normal-vs-Age(41-60Yrs) |
6.75909994640733E-09 |
| Normal-vs-Age(61-80Yrs) |
1.078450E-02 |
| Normal-vs-Age(81-100Yrs) |
3.581400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.794400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.336200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.142600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.393800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.035400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.607200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.903200E-01 |
| Classical-VS-Follicular |
2.011600E-02 |
| Classical-VS-Other |
2.826400E-01 |
| Classical-VS-Normal |
1.74670278241251E-11 |
| Tall-VS-Follicular |
1.646350E-01 |
| Tall-VS-Other |
2.714600E-01 |
| Tall-VS-Normal |
6.577300E-04 |
| Follicular-VS-Other |
1.349850E-01 |
| Follicular-VS-Normal |
2.417500E-02 |
| Other-VS-Normal |
1.894080E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.67960000030787E-07 |
| Normal-vs-N1 |
1.77321000000008E-05 |
| N0-vs-N1 |
1.006360E-01 |
|
|
